Medical University of Innsbruck — Innsbruck

Public research footprint of Medical University of Innsbruck, compiled from the ClinicalTrials.gov public registry.

147

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis · IDH-mutant Grade 2 or 3 Astrocytoma · Patients With Heart Failure Undergoing Cardiac Surgery · Clonal Hematopoiesis of Indeterminate Potential (CHIP)

Recently updated registry entries

NCT06571149 — Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and… (Recruiting)
NCT07332091 — Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator… (Recruiting)
NCT06809322 — Vorasidenib Maintenance for IDH Mutant Astrocytoma (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Medical University of Innsbruck?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.